FR2303562A1 - Nouvelle preparation d'antigene utilisable comme vaccin - Google Patents

Nouvelle preparation d'antigene utilisable comme vaccin

Info

Publication number
FR2303562A1
FR2303562A1 FR7508046A FR7508046A FR2303562A1 FR 2303562 A1 FR2303562 A1 FR 2303562A1 FR 7508046 A FR7508046 A FR 7508046A FR 7508046 A FR7508046 A FR 7508046A FR 2303562 A1 FR2303562 A1 FR 2303562A1
Authority
FR
France
Prior art keywords
vaccine
antigen preparation
new antigen
new
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7508046A
Other languages
English (en)
Other versions
FR2303562B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COMMUNITY BLOOD COUNCIL GREATE
Original Assignee
COMMUNITY BLOOD COUNCIL GREATE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COMMUNITY BLOOD COUNCIL GREATE filed Critical COMMUNITY BLOOD COUNCIL GREATE
Priority to FR7508046A priority Critical patent/FR2303562A1/fr
Priority to US05/631,961 priority patent/US4118479A/en
Priority to SE7602871A priority patent/SE437329B/xx
Priority to ZA761346A priority patent/ZA761346B/xx
Priority to BE164943A priority patent/BE839306A/fr
Priority to AU11967/76A priority patent/AU505999B2/en
Priority to MX000071U priority patent/MX3473E/es
Priority to CA248,345A priority patent/CA1066190A/fr
Priority to NL7602621A priority patent/NL7602621A/xx
Priority to DE2610717A priority patent/DE2610717C3/de
Priority to JP51028011A priority patent/JPS51133414A/ja
Priority to AT186276A priority patent/AT349136B/de
Publication of FR2303562A1 publication Critical patent/FR2303562A1/fr
Priority to US05/771,728 priority patent/US4118478A/en
Priority to US05/831,327 priority patent/US4164565A/en
Application granted granted Critical
Publication of FR2303562B1 publication Critical patent/FR2303562B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FR7508046A 1975-03-14 1975-03-14 Nouvelle preparation d'antigene utilisable comme vaccin Granted FR2303562A1 (fr)

Priority Applications (14)

Application Number Priority Date Filing Date Title
FR7508046A FR2303562A1 (fr) 1975-03-14 1975-03-14 Nouvelle preparation d'antigene utilisable comme vaccin
US05/631,961 US4118479A (en) 1975-03-14 1975-11-17 Vaccine for active immunization containing hepatitis B surface antigen and associated antigen
SE7602871A SE437329B (sv) 1975-03-14 1976-02-27 Sett att ur blodserum framstella vaccin mot virushepatit
ZA761346A ZA761346B (en) 1975-03-14 1976-03-05 Vaccine for active immunization containing hepatitis b surface antigen and associated antigen
BE164943A BE839306A (fr) 1975-03-14 1976-03-08 Vaccin d'immunisation active contre l'hepatite virale et procede de preparation
MX000071U MX3473E (es) 1975-03-14 1976-03-12 Procedimiento para la preparacion de una vacuna contra hepatitis viral
AU11967/76A AU505999B2 (en) 1975-03-14 1976-03-12 Hepatitis vaccine
CA248,345A CA1066190A (fr) 1975-03-14 1976-03-12 Vaccin pour immunisation active contenant l'antigene hb de (surface) et l'antigene associe a l'hepatite
NL7602621A NL7602621A (nl) 1975-03-14 1976-03-12 Werkwijze voor het bereiden van een vaccin tegen virale hepatitis.
DE2610717A DE2610717C3 (de) 1975-03-14 1976-03-13 Hepatitis-B-Impfstoff und Verfahren zu seiner Herstellung
JP51028011A JPS51133414A (en) 1975-03-14 1976-03-15 Production of vaccine against viral hepatisis
AT186276A AT349136B (de) 1975-03-14 1976-03-15 Verfahren zur herstellung einer hepatitis- virus-vakzine
US05/771,728 US4118478A (en) 1975-03-14 1977-02-24 Vaccine manufacture for active immunization containing hepatitis B surface antigen and associated antigen
US05/831,327 US4164565A (en) 1975-03-14 1977-09-07 Vaccine for active immunization containing hepatitis B surface antigen and associated antigen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7508046A FR2303562A1 (fr) 1975-03-14 1975-03-14 Nouvelle preparation d'antigene utilisable comme vaccin

Publications (2)

Publication Number Publication Date
FR2303562A1 true FR2303562A1 (fr) 1976-10-08
FR2303562B1 FR2303562B1 (fr) 1978-08-04

Family

ID=9152597

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7508046A Granted FR2303562A1 (fr) 1975-03-14 1975-03-14 Nouvelle preparation d'antigene utilisable comme vaccin

Country Status (4)

Country Link
US (1) US4118479A (fr)
BE (1) BE839306A (fr)
FR (1) FR2303562A1 (fr)
ZA (1) ZA761346B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2750045A1 (de) * 1977-11-09 1979-05-10 Behringwerke Ag Verfahren zur entfernung von detergentien aus virusantigensuspensionen
US4181713A (en) * 1978-10-30 1980-01-01 Merck & Co., Inc. Isolation of HBs Ag
JPS5610119A (en) * 1979-07-05 1981-02-02 Alpha Therapeutic Corp Manufacture of b type hepatitis infection preventive vaccine
US4412985A (en) * 1980-10-06 1983-11-01 Edward Shanbrom Depyrogenation process
US4617260A (en) * 1981-02-27 1986-10-14 Merck & Co., Inc. RIA assay for HBcAg
PL133476B1 (en) * 1981-06-10 1985-06-29 Akad Medyczna Method of obtaining pure antigen hba from human serum
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
GB8321789D0 (en) * 1983-08-12 1983-09-14 Biogen Nv Vaccines and compositions against hepatitis
US5324513A (en) * 1984-03-07 1994-06-28 Institut Pasteur Composition useful for the fabrication of vaccines
US4649192A (en) * 1985-05-30 1987-03-10 Smith Kline-Rit Method for the isolation and purification of hepatitis B surface antigen using polysorbate
WO1995016040A2 (fr) * 1993-12-10 1995-06-15 The Canadian Red Cross Society Titrage par immunofluorescence concernant la detection d'anticorps et utilisant des antigenes recombines sous forme non soluble

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1356413A (en) * 1971-09-09 1974-06-12 Pfizer Ltd Method of obtaining purified australia antigen from blood serum
US3951937A (en) * 1973-12-20 1976-04-20 The Community Blood Council Of Greater New York, Inc. Large scale purification of hepatitis type B antigen using polyethylene glycol
US3976767A (en) * 1975-04-14 1976-08-24 The New York Blood Center Purification of hepatitis B surface antigen by chromatography on agarose containing aminoalkyl residues

Also Published As

Publication number Publication date
BE839306A (fr) 1976-07-01
US4118479A (en) 1978-10-03
FR2303562B1 (fr) 1978-08-04
ZA761346B (en) 1977-02-23

Similar Documents

Publication Publication Date Title
MX4328E (es) Procedimiento para preparar corticoides a partir de androstenos
AT365448B (de) Kosmetische zubereitung
BE842813A (fr) Agrafe chirurgicale
SE433804B (sv) Forfarande for framstellning av en farmaceutisk lekemedelsberedning i kapselform med retardeffekt
BE858992A (fr) Procede de preparation de vaccins
SE7604818L (sv) Vaccin
FR2303562A1 (fr) Nouvelle preparation d'antigene utilisable comme vaccin
FR2297615A1 (fr) Nouvelles perhalogenoalcoylamidines substituees comme stimulants cardiaques
MX5976E (es) Procedimiento mejorado para preparar una composicion farmaceutica a partir de cefalexina
BE846054A (fr) Recuperation d'alkylene-glycols
FR2293944A1 (fr) Antigene de l'hepatite a
SE7800781L (sv) Nytt vaccin
FR2282908A1 (fr) Vaccin contre la colibacillose
BE750349A (fr) Vaccin destine a l'immunisation active comprenant comme adjuvant le diethylaminoethyldextrane
BE858005A (fr) Polyesters ramifies utilisables comme adjuvants de teinturerie
SE7813201L (sv) Vaccin
FR2305195A1 (fr) Vaccin polysaccharide de meningocoque
BE847343A (fr) Antigene d'hepatite a,
IT1078023B (it) Apparecchio per evitare l'arricciatura delle cimosse di tessuti a maglia
SE426550B (sv) Forfarande for framstellning av ett vaccin mot panleukopeni hos katt
BE850141A (fr) Vaccin
JPS51142528A (en) Production of vaccine based on antigenic libosome fractionation
MX142878A (es) Mejoras a mecanismo de brazos de union
MX5355E (es) Procedimiento para la preparacion del hemicetal 3 a alfa-h-4-alfa(3'-propanol)-7-a beta-metilhexahidro-1,5-indandiona
BE818797A (fr) Antigene de tetanos

Legal Events

Date Code Title Description
ST Notification of lapse